Priscila Santos Scheucher

722 total citations
41 papers, 488 citations indexed

About

Priscila Santos Scheucher is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Priscila Santos Scheucher has authored 41 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 23 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Priscila Santos Scheucher's work include Acute Myeloid Leukemia Research (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Priscila Santos Scheucher is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Priscila Santos Scheucher collaborates with scholars based in Brazil, United States and Lebanon. Priscila Santos Scheucher's co-authors include Bárbara A. Santana-Lemos, Eduardo Magalhães Rego, Rodrigo T. Calado, Fernanda Gutierrez‐Rodrigues, Roberto Passetto Falcão, João Agostinho Machado‐Neto, Fabı́ola Traina, Guilherme Augusto dos Santos, Juan Luiz Coelho‐Silva and Antonio R. Lucena‐Araujo and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Priscila Santos Scheucher

37 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Priscila Santos Scheucher Brazil 12 285 117 108 101 64 41 488
Bárbara A. Santana-Lemos Brazil 13 292 1.0× 141 1.2× 52 0.5× 136 1.3× 54 0.8× 18 512
Juliette Berger France 12 237 0.8× 81 0.7× 50 0.5× 79 0.8× 45 0.7× 28 425
Yong‐Mei Guo Japan 11 283 1.0× 130 1.1× 185 1.7× 49 0.5× 120 1.9× 28 543
Usawadee Dier United States 7 216 0.8× 43 0.4× 126 1.2× 61 0.6× 34 0.5× 9 409
Daniela Di Marcantonio United States 15 417 1.5× 29 0.2× 66 0.6× 86 0.9× 49 0.8× 29 569
Simon Haefliger Switzerland 12 342 1.2× 24 0.2× 204 1.9× 135 1.3× 49 0.8× 33 604
Heather Glaser United States 9 512 1.8× 33 0.3× 67 0.6× 167 1.7× 75 1.2× 9 636
Jia-Xi Mao China 7 733 2.6× 80 0.7× 110 1.0× 92 0.9× 17 0.3× 16 935
Sheng-Fung Lin Taiwan 10 243 0.9× 35 0.3× 109 1.0× 72 0.7× 34 0.5× 23 380
Qi Zhu China 12 245 0.9× 23 0.2× 81 0.8× 80 0.8× 82 1.3× 35 450

Countries citing papers authored by Priscila Santos Scheucher

Since Specialization
Citations

This map shows the geographic impact of Priscila Santos Scheucher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priscila Santos Scheucher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priscila Santos Scheucher more than expected).

Fields of papers citing papers by Priscila Santos Scheucher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priscila Santos Scheucher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priscila Santos Scheucher. The network helps show where Priscila Santos Scheucher may publish in the future.

Co-authorship network of co-authors of Priscila Santos Scheucher

This figure shows the co-authorship network connecting the top 25 collaborators of Priscila Santos Scheucher. A scholar is included among the top collaborators of Priscila Santos Scheucher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priscila Santos Scheucher. Priscila Santos Scheucher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garcia, Camila Araújo Bernardino, Leonardo Carvalho Palma, Priscila Santos Scheucher, et al.. (2024). Immune Content of Mature and Licensed Cytotoxic Cells Is Associated with Treatment-Free Remission in Chronic Myeloid Leukemia. Blood. 144(Supplement 1). 1756–1756.
2.
Pereira‐Martins, Diego A., Leonardo Carvalho Palma, Priscila Santos Scheucher, et al.. (2022). Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms. Frontiers in Immunology. 13. 768592–768592. 1 indexed citations
3.
Fonseca, Natasha Peixoto, Juan Luiz Coelho‐Silva, Priscila Santos Scheucher, et al.. (2022). Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells. Toxicology in Vitro. 83. 105384–105384. 1 indexed citations
4.
Gutierrez‐Rodrigues, Fernanda, et al.. (2021). Association between leukocyte telomere length and sex by quantile regression analysis. Hematology Transfusion and Cell Therapy. 44(3). 346–351. 6 indexed citations
5.
Scopim‐Ribeiro, Renata, João Agostinho Machado‐Neto, Christopher A. Eide, et al.. (2021). NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia. Investigational New Drugs. 39(3). 736–746. 7 indexed citations
6.
Coelho‐Silva, Juan Luiz, Renata Scopim‐Ribeiro, Priscila Santos Scheucher, et al.. (2020). NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells. Signal Transduction and Targeted Therapy. 5(1). 5–5. 24 indexed citations
7.
Almeida, Luciana Yamamoto, et al.. (2020). Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome. BMC Cancer. 20(1). 821–821. 2 indexed citations
8.
Machado‐Neto, João Agostinho, Renata Scopim‐Ribeiro, Christopher A. Eide, et al.. (2018). Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms. Cell Death and Disease. 9(3). 311–311. 19 indexed citations
9.
Machado‐Neto, João Agostinho, Juan Luiz Coelho‐Silva, Fábio Pires de Souza Santos, et al.. (2018). Autophagy Inhibition Potentiates Ruxolitinib-Induced Apoptosis in JAK2V617F Cells. Blood. 132(Supplement 1). 1788–1788. 2 indexed citations
10.
Machado‐Neto, João Agostinho, Paula de Melo Campos, Juan Luiz Coelho‐Silva, et al.. (2017). The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms. Blood. 130. 1253. 2 indexed citations
11.
Coelho‐Silva, Juan Luiz, et al.. (2017). IGF signaling predicts outcomes and is a promising target therapy for acute myeloid leukemia. Blood. 130. 3966–3966.
12.
Machado‐Neto, João Agostinho, et al.. (2016). Reversine triggers mitotic catastrophe and apoptosis in BCR-ABL positive cells. Haematologica. 101. 733. 1 indexed citations
13.
Machado‐Neto, João Agostinho, et al.. (2016). Reversine triggers mitotic catastrophe and apoptosis in K562 cells. Leukemia Research. 48. 26–31. 16 indexed citations
14.
Lucena‐Araujo, Antonio R., Guilherme Augusto dos Santos, Dalila Lucíola Zanette, et al.. (2013). Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia. Experimental Hematology and Oncology. 2(1). 10–10. 44 indexed citations
15.
Santos, Guilherme Augusto dos, Carolina Hassibe Thomé, Priscila Santos Scheucher, et al.. (2011). Linker of Activation of T Cells – 2 (LAT2), a Lipid Raft-Associated Adaptor Protein, Is a Novel Target for Therapy in Acute Leukemia. Blood. 118(21). 737–737. 1 indexed citations
16.
Santos, Guilherme Augusto dos, Carolina Hassibe Thomé, Thatyane M. Nobre, et al.. (2010). Interaction of 10-(octyloxy) decyl-2-(trimethylammonium) ethyl phosphate with mimetic membranes and cytotoxic effect on leukemic cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1798(9). 1714–1723. 12 indexed citations
17.
18.
Zanette, Dalila Lucíola, Guilherme Augusto dos Santos, Priscila Santos Scheucher, et al.. (2009). Aberrant Expression of Mir-29b, Mir-181a and Mir-181b in T-Cell Acute Lymphoblastic Leukemia.. Blood. 114(22). 3065–3065. 1 indexed citations
19.
Santos, Guilherme Augusto dos, Priscila Santos Scheucher, Antonio R. Lucena‐Araujo, et al.. (2008). Apoptosis induction by (+)α-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells. Leukemia Research. 33(7). 958–963. 11 indexed citations
20.
Santana, Bárbara A., Priscila Santos Scheucher, Guilherme Augusto dos Santos, et al.. (2006). Asynchronous expression of myeloid antigens in leukemic cells in a PML/RARalpha transgenic mouse model. Brazilian Journal of Medical and Biological Research. 39(5). 615–620. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bárbara A. Santana-Lemos Breakdown of academic impact, for papers by Juliette Berger Breakdown of academic impact, for papers by Yong‐Mei Guo Breakdown of academic impact, for papers by Usawadee Dier Breakdown of academic impact, for papers by Daniela Di Marcantonio Breakdown of academic impact, for papers by Simon Haefliger Breakdown of academic impact, for papers by Heather Glaser Breakdown of academic impact, for papers by Jia-Xi Mao Breakdown of academic impact, for papers by Sheng-Fung Lin Breakdown of academic impact, for papers by Qi Zhu
Rankless by CCL
2026